Gemtesa (Vibegron)

Vibegron is a medicine for an overactive bladder, which causes sudden strong urges to pee and leaks. It is taken as a pill once a day. It works by relaxing the bladder muscle so the bladder can hold more urine.

Brand names:Gemtesa
Medication

What people taking Gemtesa (Vibegron) report

Every report comes from a Lived member, sent anonymously.

Have you tried Gemtesa (Vibegron) for Overactive Bladder?

NameHow it went

About Gemtesa (Vibegron)

What It's For

Vibegron, sold as Gemtesa, is a once-daily prescription tablet for overactive bladder (OAB) in adults. Overactive bladder describes sudden urges to urinate that are hard to put off (urgency), needing to go much more often than usual (frequency), and, for some people, leaking urine before reaching a toilet (urge incontinence). Gemtesa is approved to treat all three symptoms in adults. It is also approved for men who have these symptoms while already taking medicine for an enlarged prostate (benign prostatic hyperplasia, or BPH). Vibegron belongs to a small group of medicines called beta-3 agonists; mirabegron is the other one available in the US. The older family of bladder pills, antimuscarinics, works in a different way, and US urology guidelines ask clinicians to discuss a possible link between long-term antimuscarinic use and dementia. That guidance is specific to antimuscarinics, and it is one reason some people and their clinicians start with, or switch to, a beta-3 agonist. Medicine is usually one part of treatment: guidelines recommend bladder training and other behavioral approaches for everyone with OAB, with or without a pill.

How It Works

The wall of the bladder is a muscle called the detrusor. As the bladder fills, this muscle normally stays relaxed and only squeezes when it is time to urinate. In overactive bladder, it tends to tighten too early, which produces the sudden, strong urge to go even when the bladder is not full. Vibegron activates beta-3 receptors on the detrusor, a signal that helps the muscle relax while the bladder is filling. A more relaxed bladder can hold more urine before it sends an urgent signal, so people tend to feel fewer sudden urges, make fewer trips and leak less often. In the main trial, the average amount passed each time rose by about 20 mL more than with a placebo (a dummy pill), a sign that the bladder was holding more.

Dosage & Administration

Gemtesa comes in one strength, a 75 mg tablet taken once a day, with or without food. Because there is only one dose, there is no gradual build-up. Swallow the tablet whole with a glass of water. Adults who find tablets hard to swallow can crush it, mix it into about a tablespoon of applesauce, and take it straight away, followed by a glass of water. No dose change is needed for mild to severe kidney disease or for mild to moderate liver disease. Vibegron has not been studied in kidney failure, meaning an eGFR (estimated glomerular filtration rate, a blood-test measure of kidney function) below 15, whether or not someone is on dialysis, or in severe liver disease, and it is not recommended in either situation.

Side Effects

The side effects reported more often than with a placebo were headache, urinary tract infections, cold-like symptoms such as a sore throat or stuffy nose, diarrhea and nausea, each affecting a small share of people (roughly 2 to 4 in 100 in the trials). Dry mouth, constipation and hot flushes were less common. In men taking it alongside prostate medicine, high blood pressure readings were about as common as with a placebo. Vibegron can occasionally make it hard to empty the bladder fully, called urinary retention. Signs include a weak or slow stream, straining to start, or feeling that the bladder has not emptied after going. Contact the prescriber promptly if these appear; the medicine is stopped if retention develops. Rarely, vibegron causes angioedema, a deep swelling of the face, lips, tongue or throat. It has appeared hours after the first dose and also after many doses. Swelling of the tongue or throat, or trouble breathing or swallowing, can be life-threatening: stop the medicine and call 911 or get emergency care right away. Hives, itching or a rash should also be reported.

Interactions & Warnings

Do not take vibegron after a previous allergic reaction to it or to anything in the tablet. The risk of urinary retention is higher in people whose urine flow is already partly blocked, for example by an enlarged prostate (bladder outlet obstruction), and in people who also take an antimuscarinic bladder medicine. Combining the two kinds of bladder medicine can be reasonable when one alone is not enough, but it calls for closer attention to how well the bladder empties. Vibegron raises blood levels of digoxin, a heart medicine used for heart failure and some irregular heart rhythms. Anyone taking digoxin should have levels checked before starting vibegron, during treatment and again after stopping it, so the digoxin dose can be adjusted. Unlike mirabegron, vibegron's label carries no warning about severe uncontrolled high blood pressure. There are no human data on vibegron in pregnancy or breastfeeding, so anyone pregnant, planning a pregnancy or breastfeeding should weigh the need for it with the prescriber. It is not approved for children.

What to Expect

Guidelines suggest checking how well a bladder medicine is working, and how it is being tolerated, about 4 to 8 weeks after starting. Keeping a simple bladder diary (trips, urges and leaks per day) before and during treatment makes that review more concrete. It helps to know what the trials actually showed. Adults who began with about 11 trips to the toilet and 3 to 4 leaks a day had about 2 fewer leaks a day after 12 weeks on vibegron, compared with about 1.4 fewer on a placebo, and slightly fewer trips. Some people improve a great deal and others very little, and part of the improvement seen in trials happens with a placebo too. Bladder training and changes such as spacing fluids through the day add to the effect of the tablet. If the benefit is not enough, options include switching to a different medicine, adding one from the other family, or moving on to treatments such as botulinum toxin injections into the bladder or nerve stimulation. Vibegron has been studied for up to a year of continuous use.

Questions to Ask Your Doctor

  1. 1.Is vibegron a better fit for me than an antimuscarinic medicine or mirabegron, given my age, other conditions and other medicines?
  2. 2.What change in urges, trips or leaks should I expect, and when will we review whether it is working?
  3. 3.Does anything about my bladder or prostate make urinary retention more likely for me, and how would we check?
  4. 4.Do any of my current medicines, such as digoxin, need monitoring or a dose change while I take vibegron?
  5. 5.If vibegron is not enough on its own, what would we try next?

Last reviewed • Oct 2026

Educational content, not medical advice.